Unlock instant, AI-driven research and patent intelligence for your innovation.

Preparation and application for porcine epidemic diarrhea subunit vaccine

A vaccine composition, amino acid technology, applied in medical preparations containing active ingredients, microorganism-based methods, biochemical equipment and methods, etc., can solve problems such as infection and death of newborn piglets, and achieve large-scale production convenience and immunity Good, the effect of preventing diarrheal diseases

Pending Publication Date: 2018-09-28
杨凌凯瑞生物科技有限公司
View PDF6 Cites 8 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Although the above types of vaccines are widely used in pig farms, PED outbreaks occur in different regions of my country every year, causing a large number of newborn piglets to die of infection

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Preparation and application for porcine epidemic diarrhea subunit vaccine
  • Preparation and application for porcine epidemic diarrhea subunit vaccine
  • Preparation and application for porcine epidemic diarrhea subunit vaccine

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0025] Example 1: Preparation, identification and content determination of fusion protein S1-RBD-Fc.

[0026] Preparation and Identification of Porcine Epidemic Diarrhea Virus Fusion Protein

[0027] 1.1.1 Construction of recombinant vector

[0028] According to the nucleic acid sequence described in the sequence table SEQ ID NO.2, it was synthesized by Wuhan Jinkairui Biotechnology Co., Ltd. by artificial synthesis, and the total length of the synthesized gene was 1223bp. Using the synthetic gene as a template, design a pair of specific primers, the sequence is as follows: Fla-S-his6-F1: 5'-CGGGAATTCAACATTAACAACAACTTGC-3';

[0029] Fla-S-his6-R1: 5'-CGGCTCGAGCTTACCTGGAGACAAAGAC-3'.

[0030] Fragments were amplified by PCR. The PCR conditions were: pre-denaturation at 98°C for 2 min, denaturation at 98°C for 15 s, annealing at 56°C for 30 s, extension at 72°C for 30 s, 30 cycles, and extension at 72°C for 5 min.

[0031] The PCR product was electrophoresed on 1% agarose ge...

Embodiment 2

[0044] Embodiment 2: preparation and purity test of vaccine composition

[0045] 2.1 Adjuvant preparation

[0046] Preparation of MF59 adjuvant (containing 5% squalane, 1% oleic acid, 1% Tween 60, 93% 0.005M sodium citrate): Stir and mix the prescribed amount of Tween 80 and sodium citrate buffer, and then Add the prescribed amount of oleic acid and squalane, and use a high-pressure homogenizer at 1200 bar for 5 cycles, then collect the feed liquid and filter it through a 0.22 μm PTFE membrane to sterilize;

[0047] 2.2 Vaccine ratio

[0048] The fusion protein was administered in doses of 10, 20, 50, 100 μg and the adjuvant at a ratio of 1:1 in a sterile environment, stirred and mixed evenly, marked and grouped.

[0049] Table 2 Animal group record form

[0050] group

Embodiment 3

[0051] Embodiment 3: Animal evaluation experiment of vaccine composition

[0052] 3.1 Animal safety test of vaccine composition

[0053] 3.1.1 Character test The appearance of the vaccine composition is pink latex, without layering.

[0054] 3.1.2 Sterility test The vaccine composition was tested according to the third appendix of the current Veterinary Pharmacopoeia of the People's Republic of China in 2010, and no colonies were observed in T.G, G.P tubes and G.A slant medium.

[0055] 3.1.3 Safety inspection 24 3-day-old pigs that were negative for porcine PEDV virus antibody and antigen were randomly divided into 4 groups, 6 pigs in each group, and 10 pigs were injected intramuscularly with the vaccine. Clinical observation was carried out for 14 days, and all 6 / 6 pigs were healthy. live, no adverse reactions occurred.

[0056] Vaccine Composition Neutralizing Antibody Level Test

[0057] 1) Materials and methods

[0058] Get 30 pregnant sows that were negative for pig ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The present invention provides a vaccine composition for porcine epidemic diarrhea and an application of the vaccine composition. The vaccine composition comprises a porcine epidemic diarrhea subunitantigen and an adjuvant of the subunit antigen, the subunit antigen is a fusion protein formed by tandem expression of a receptor binding region of an S1 core antigen and an Fc fragment of an immune globulin, and the fusion protein can be efficiently expressed and secreted by pichia pastoris, has a simple process and low costs, and is convenient for large-scale production. The invention also provides a preparation method and vaccine effect of the subunit vaccine. The vaccine composition provided by the present invention can produce a higher neutralizing antibody titer than a market inactivatedvaccine through immunizing mice, and avoids the problem that whole viruses are difficult to separate and cultivate in large scale in inactivation preparation.

Description

Technical field: [0001] The invention belongs to the technical field of veterinary biological products, and in particular relates to the preparation and application of a subunit antigen of porcine epidemic diarrhea virus and a vaccine composition emulsified with an adjuvant. Background technique: [0002] Epidemic diarrhea (PED) is an acute, highly contagious intestinal infectious disease of pigs caused by porcine epidemic diarrhea virus (PEDV), characterized by diarrhea, vomiting, dehydration, and high mortality. PED, mainly caused by PEDV mutant strains, is widely prevalent in various provinces in my country, with an incidence rate of 20%-100% and a mortality rate of 40%-100%, which has caused serious economic losses to my country's pig industry. At present, there is no effective drug for the treatment of PED, and vaccination is the main means of prevention and control of PED. [0003] The vaccines currently on the market are mainly PED inactivated vaccines, PED attenuated...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C07K19/00C12N1/19A61K39/215A61P31/14A61P1/12C12R1/865
CPCA61K39/12A61P1/12A61P31/14C07K14/005C07K2319/30C12N2770/20034C12N2770/20022A61K2039/55566
Inventor 杜恩岐左文峰余勉王荣陈瑞
Owner 杨凌凯瑞生物科技有限公司